However, although the total number of microglial cells did not differ between Egln3−/−; APP-PSEN1/+ and APP-PSEN1/+ mice, microglial cells expressed higher levels of CD45 in AD mice lacking PHD3 (Fig. 4C), suggesting a change in activation status (53). This evidence concerns the gene EGLN3 and Alzheimer disease.